BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 10344528)

  • 1. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA; Constantino MD; Ribeiro JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
    Mazzoni MR; Giusti L; Rossi E; Taddei S; Lucacchini A
    Biochim Biophys Acta; 1997 Feb; 1324(1):159-70. PubMed ID: 9059509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum.
    Johansson B; Georgiev V; Parkinson FE; Fredholm BB
    Eur J Pharmacol; 1993 Oct; 247(2):103-10. PubMed ID: 8281998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography.
    Johansson B; Fredholm BB
    Neuropharmacology; 1995 Apr; 34(4):393-403. PubMed ID: 7566470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.
    Lindström K; Ongini E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):539-41. PubMed ID: 8897460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat.
    Cunha RA; Constantino MC; Sebastião AM; Ribeiro JA
    Neuroreport; 1995 Jul; 6(11):1583-8. PubMed ID: 7579154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats.
    Lopes LV; Cunha RA; Ribeiro JA
    J Neurochem; 1999 Oct; 73(4):1733-8. PubMed ID: 10501222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.
    Lopes LV; Cunha RA; Ribeiro JA
    J Neurophysiol; 1999 Dec; 82(6):3196-203. PubMed ID: 10601453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of adenosine receptors in brush-border membranes from pig kidney.
    Blanco J; Canela EI; Mallol J; Lluís C; Franco R
    Br J Pharmacol; 1992 Nov; 107(3):671-8. PubMed ID: 1335333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    Fredholm BB; Lindström K
    Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilisation and immunoprecipitation of rat striatal adenosine A(2A) receptors.
    Harvey V; Jones J; Misra A; Knight AR; Quirk K
    Eur J Pharmacol; 2001 Nov; 431(2):171-7. PubMed ID: 11728423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors.
    Luthin DR; Linden J
    J Pharmacol Exp Ther; 1995 Feb; 272(2):511-8. PubMed ID: 7853164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.